Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: A 24-week randomized, double-blind exploratory study.

The requested reference [4663dc21ef5ccc496cd55504a8df5de1c4186c45] no longer exists in our database. It has been replaced by the current reference: [c904c79186c34593144def3f9deb358238e895e9]

Authors
Category Primary study
JournalNeuropsychiatric Disease and Treatment
Year 2010
This article has no abstract
Epistemonikos ID: bdc8ad8870a63a1986cbc53d7982a9e37f9b6ab3
First added on: May 07, 2025